Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiran J Philip

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Vascular Health and Risk Management|May 19, 2010
The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertensionJeremy A Falk, Kiran J Philip, Ernst R Schwarz
Journal of Cardiovascular Pharmacology and Therapeutics|November 25, 2010
Clinical applications of bivalirudin in the cardiac catheterization laboratoryKeith A Thompson, Kiran J Philip, Ernst R Schwarz
Journal of Cardiovascular Pharmacology and Therapeutics|July 3, 2010
The new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantationKeith A Thompson, Kiran J Philip, Sinan Simsir, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 31, 2010
Heart failure therapy: beyond the guidelinesKeith A Thompson, Parag Bharadwaj, Kiran J Philip, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 4, 2010
Review article: the new concept of interventional heart failure therapy--part 1: electrical therapy, treatment of CAD, fluid removal, and ventricular supportKeith A Thompson, Kiran J Philip, Alejandro Barbagelata, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 25, 2010
Testosterone therapy: treatment of metabolic disturbances in heart failureJesse J Naghi, Kiran J Philip, Deanna DiLibero, et al.
Journal of Religion and Health|January 11, 2013
The effects of spirituality and religion on outcomes in patients with chronic heart failureJesse J Naghi, Kiran J Philip, Anita Phan, et al.
Therapeutic Advances in Cardiovascular Disease|October 18, 2013
Left ventricular noncompaction cardiomyopathy: updated reviewDioma U Udeoji, Kiran J Philip, Ryan P Morrissey, et al.
Journal of Religion and Health|March 2, 2010
Maximal care considerations when treating patients with end-stage heart failure: ethical and procedural quandaries in management of the very sickErnst R Schwarz, Kiran J Philip, Sinan A Simsir, et al.
Vascular Medicine (London, England)|September 13, 2019
Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery systemKristi Reynolds, Katherine E Mues, Teresa N Harrison, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vascular Health and Risk Management|May 19, 2010
The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertensionJeremy A Falk, Kiran J Philip, Ernst R Schwarz
Journal of Cardiovascular Pharmacology and Therapeutics|November 25, 2010
Clinical applications of bivalirudin in the cardiac catheterization laboratoryKeith A Thompson, Kiran J Philip, Ernst R Schwarz
Journal of Cardiovascular Pharmacology and Therapeutics|July 3, 2010
The new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantationKeith A Thompson, Kiran J Philip, Sinan Simsir, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 31, 2010
Heart failure therapy: beyond the guidelinesKeith A Thompson, Parag Bharadwaj, Kiran J Philip, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 4, 2010
Review article: the new concept of interventional heart failure therapy--part 1: electrical therapy, treatment of CAD, fluid removal, and ventricular supportKeith A Thompson, Kiran J Philip, Alejandro Barbagelata, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 25, 2010
Testosterone therapy: treatment of metabolic disturbances in heart failureJesse J Naghi, Kiran J Philip, Deanna DiLibero, et al.
Journal of Religion and Health|January 11, 2013
The effects of spirituality and religion on outcomes in patients with chronic heart failureJesse J Naghi, Kiran J Philip, Anita Phan, et al.
Therapeutic Advances in Cardiovascular Disease|October 18, 2013
Left ventricular noncompaction cardiomyopathy: updated reviewDioma U Udeoji, Kiran J Philip, Ryan P Morrissey, et al.
Journal of Religion and Health|March 2, 2010
Maximal care considerations when treating patients with end-stage heart failure: ethical and procedural quandaries in management of the very sickErnst R Schwarz, Kiran J Philip, Sinan A Simsir, et al.
Vascular Medicine (London, England)|September 13, 2019
Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery systemKristi Reynolds, Katherine E Mues, Teresa N Harrison, et al.
Pageof 1